Emily Martin

Has grant

Associate Professor

University of Tennessee Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Emily Martin is an Associate Professor at the University of Tennessee Medical Center in the United States. Her research primarily focuses on amyloid imaging and the development of novel radiotracers, as evidenced by her recent publications exploring peptide binding to glycosaminoglycans and the efficacy of new imaging techniques for systemic amyloidosis. She has contributed significantly to the understanding of amyloid clearance mechanisms and the clinical application of PET/CT imaging in diagnosing amyloid-related diseases.

Recent Grants

Grant: Close

Development of an assay to determine the amyloidogenic propensity of light chain proteins – A metric for identifying at-risk patients

Open Date: 2017-01-01

Close Date: 2017-12-01

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Collaborators (3)

Joseph Jackson

Assistant Professor

University of Tennessee Medical Center

UNITED STATES

View details

Jonathan S. Wall

University of Tennessee Graduate School of Medicine

UNITED STATES

View details

Trevor Hancock

Assistant Professor

University of Tennessee Health Science Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Emily Martin

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Pan-Amyloid Reactive Peptides p5+14 and p5R Exhibit Specific Charge-Dependent Binding to Glycosaminoglycans

A tale of two tracers - Amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05)

The antibody-peptide fusion protein, AT-02, is an effective opsonin with pan-amyloid reactivity

Longitudinal PET/CT imaging with iodine (124I) evuzamitide reveals organ response to plasma cell immunotherapy in a patient with AL amyloidosis

Neutrophils enhance the clearance of systemic amyloid deposits in a murine amyloidoma model

Collagen inhibits phagocytosis of amyloid in vitro and in vivo and may act as a ‘don’t eat me’ signal

Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide 124I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging

Development and characterization of a prototypic pan-amyloid clearing agent – a novel murine peptide-immunoglobulin fusion

Cardiac Amyloid Detection by PET/CT Imaging of Iodine (124I) Evuzamitide (124I-p5+14): A Phase 1/2 Study

First in Human Evaluation and Dosimetry Calculations for Peptide 124I-p5+14—a Novel Radiotracer for the Detection of Systemic Amyloidosis Using PET/CT Imaging

Discrete binding patterns of two heparin-reactive proteins, basic fibroblast growth factor and peptide p5R, in amyloid-laden and healthy mice

Collaborators (3)

Joseph Jackson

Jonathan S. Wall

Trevor Hancock

Make your next move.